Adequacy of Pain Treatment in Radiotherapy: an Observational, Prospective, Multicenter Study (ARISE)

IRCCS Azienda Ospedaliero-Universitaria di Bologna1 site in 1 country2,000 target enrollmentMarch 1, 2018

ConditionsCancer Pain Analgesic Drugs

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer Pain
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment: 2000
Locations: 1
Primary Endpoint: Evaluation of adequacy of pain treatment
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Aim of the study is to evaluate adequacy of pain treatment in oncologic patients, accessing to Radiotherapy Unit

Detailed Description

Prescription of analgesic drugs is a basic topic in cancer patients, but undertreatment is common. The aim of the study is to analyse pain control and adequacy of antalgic treatments in patients coming to Radiotherapy Unit for radiation treatment.

Registry

clinicaltrials.gov

Start Date

March 1, 2018

End Date

June 1, 2019

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Responsible Party

Principal Investigator

Alessio Giuseppe Morganti

Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility Criteria

Inclusion Criteria

•patients accessing to Radiotherapy Unit for radiation treatment (both palliative or with radical intent) with diagnosis of primitive or metastatic cancer;

Exclusion Criteria

•Concomitant diseases that can affect reliability of collected data

Outcomes

Primary Outcomes

Evaluation of adequacy of pain treatment

Time Frame: 2 months

For all patients, Visual Analogue Scale (VAS) and information about type of analgesic drugs (no drugs; non-opioid drugs; weak opioids; strong opioids) will be recorded and analysed